Energy » Fossil Fuels | Changsheng Biotechnology Co. Ltd.

Changsheng Biotechnology Co. Ltd. A | Mutual Funds

Mutual Funds that own Changsheng Biotechnology Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
376,100
0.09%
164,500
0.31%
12/31/2017
361,800
0.09%
361,800
0.08%
12/31/2017
236,038
0.06%
-56,600
0.45%
12/31/2017
236,000
0.06%
22,300
0.08%
12/31/2017
Chang Xin CSI Central SOEs 100 Index Fund
233,600
0.06%
108,100
0.89%
12/31/2017
225,400
0.06%
225,400
0.1%
12/31/2017
160,400
0.04%
160,400
0.2%
12/31/2017
110,600
0.03%
110,600
0.23%
12/31/2017
Tianhong SSE Component Index Fund
77,432
0.02%
77,432
0.51%
12/31/2017
51,200
0.01%
51,200
0.28%
12/31/2017

About Changsheng Biotechnology Co.

View Profile
Address
No. 1615 Yueda Road
Changchun Jilin 130103
China
Employees -
Website -
Updated 07/08/2019
Changsheng Bio-technology Co., Ltd. engages in the manufacture, research and development, and sale of human vaccines. Its products include vaccine for DTC combines, rabies F and V, varicella, influenza, and hepatitis A. The company was founded on August 18, 1992 and is headquartered in Changchun, China.